In accordance with this, we found that NR2F1-AS1 was overexpressed in NSCLC samples, and that the silencing of NR2F1-AS1 inhibits the glycolysis in NSCLC cells. This evidence concerns the gene NR2F1 and non-small cell lung carcinoma.